Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia (Q46964584)
Jump to navigation
Jump to search
scientific article published on 5 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia |
scientific article published on 5 October 2007 |
Statements
1 reference
Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia (English)
1 reference
Chen Chen
1 reference
Wanlong Jiang
1 reference
Fabio Tucci
1 reference
Joe A Tran
1 reference
Beth A Fleck
1 reference
Sam R Hoare
1 reference
Margaret Joppa
1 reference
Stacy Markison
1 reference
Jenny Wen
1 reference
Yang Sai
1 reference
Michael Johns
1 reference
Ajay Madan
1 reference
Takung Chen
1 reference
Caroline W Chen
1 reference
Dragan Marinkovic
1 reference
Melissa Arellano
1 reference
John Saunders
1 reference
Alan C Foster
1 reference
5 October 2007
1 reference
1 reference
50
1 reference
22
1 reference
5249-5252
1 reference
Identifiers
1 reference
1 reference